News

Precision Medicine Online40m
Researchers in Australia Explore Potential of New CRISPR-Edited CAR T-Cell Therapy in Solid Tumors
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
Precision Medicine Online37m
Eli Lilly's Kisunla Gets New Dosing Schedule in FDA-Approved Labeling Update
The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.